Search Within

Jason Chih-Peng Chang

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (42)
  2. Meeting Abstract (41)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (86)
  2. Department of Pathology and Laboratory Medicine (86)
  3. Solid Tumor Oncology Division (86)
  4. Thoracic Oncology (79)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (55)

More Groups

People
  1. Natasha Rekhtman (56)
  2. Marc Ladanyi (45)
  3. William Travis (41)
  4. Charles Rudin (36)
  5. Alexander Drilon (28)
  6. Michael Offin (28)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (15)
  5. 2021 (20)
  6. 2020 (14)

More Years

Publications
  1. Modern Pathology (16)
  2. Laboratory Investigation (12)
  3. Journal of Thoracic Oncology (11)
  4. Clinical Cancer Research (8)
  5. Journal of Clinical Oncology (7)
  6. Cancer Discovery (5)

More Publications

Publishers
  1. Nature Publishing Group (17)
  2. American Association for Cancer Research (16)
  3. Elsevier Inc. (16)
  4. Nature Research (16)
  5. American Society of Clinical Oncology (11)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: Comparison with standard histopathologic approach
    Journal Article

    Chang, J. C.; Alex, D.; Bott, M.; Tan, K. S.; Seshan, V.; Golden, A.; Sauter, J. L.; Buonocore, D. J.; Vanderbilt, C. M.; Gupta, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Stage IV lung carcinoids: Spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
    Journal Article

    Rekhtman, N.; Desmeules, P.; Litvak, A. M.; Pietanza, M. C.; Santos-Zabala, M. L.; Ni, A.; Montecalvo, J.; Chang, J. C.; Beras, A.; Preeshagul, I. R.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements
    Journal Article

    Chang, J. C.; Zhang, L.; Drilon, A. E.; Chi, P.; Alaggio, R.; Borsu, L.; Benayed, R.; Travis, W. D.; Ladanyi, M.; Antonescu, C. R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save